Metraipolis › archive › dc_e853cb677c70
Benchmarking GPT-5 in radiation oncology: measurable gains, but persistent need for expert oversight — Europe PMC PMID:41458620
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41458620
- DOI
- 10.3389/fonc.2025.1695468
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T17:32:27.140Z
- SHA-256 of the archived text
4f827af138505fa456bb17db488f6229128895327d1b0a49f9a0015c77726113- Stable URL of this page
https://metraipolis.com/documento/dc_e853cb677c70
How to cite
Benchmarking GPT-5 in radiation oncology: measurable gains, but persistent need for expert oversight — Europe PMC PMID:41458620 — Europe PMC (en), https://europepmc.org/article/MED/41458620 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e853cb677c70 (Metraipolis archive dc_e853cb677c70, sha256 4f827af138505fa456bb17db488f6229128895327d1b0a49f9a0015c77726113)
BibTeX
@misc{dce853cb677c70,
title = {Benchmarking GPT-5 in radiation oncology: measurable gains, but persistent need for expert oversight — Europe PMC PMID:41458620},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41458620},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e853cb677c70; sha256 4f827af138505fa456bb17db488f6229128895327d1b0a49f9a0015c77726113},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41458620. Agents can read the archived copy with the MCP tool read_document.